Sofosbuvir shows promise for chronic hepatitis C infection
(HealthDay)—Sofosbuvir seems to be a promising treatment option for patients with chronic hepatitis C virus (HCV) infection, according to two studies published online April 23 in the New England Journal of ...
Diseases, Conditions, Syndromes
Apr 23, 2013 |
4 / 5 (1) |
0
|
Dual-source cardiac CT IDs CAD in hard-to-image patients
(HealthDay)—In patients who have previously been considered difficult to image, dual-source cardiac (DSC) computed tomography (CT) can identify clinically significant coronary artery disease, according ...
Cardiology
50 minutes ago |
not rated yet |
0
Fecal microbiota tx feasible for recurrent C. difficile in HIV
(HealthDay)—For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Intern ...
HIV & AIDS
May 22, 2013 |
not rated yet |
0
Discectomy post-op pain worse in patients with retrolisthesis
(HealthDay)—The presence of retrolisthesis in patients undergoing decompressive surgery for a lumbar disc herniation may result in significantly worse lower back pain and physical function over four years, ...
Diseases, Conditions, Syndromes
May 16, 2013 |
not rated yet |
0
Higher acute aortic dissection risk with lower-volume care
(HealthDay)—The mortality risk from emergency repair of acute aortic dissection is double when performed by lower-volume providers, according to research published in the May issue of the Annals of Thoracic Su ...
Cardiology
May 13, 2013 |
not rated yet |
0
Simulator-based robotic sx curriculum hones skills
(HealthDay)—A simulator-based curriculum incorporating fundamental skills of robotic surgery (FSRS) is feasible and improves effectiveness in basic robotic surgery skills, according to a study published ...
Surgery
May 13, 2013 |
not rated yet |
0
Shift in lung allocation score alters transplant survival
(HealthDay)—An acute increase in lung allocation score (LAS) before transplantation is associated with worse post-transplant survival, according to a study published in the May 7 issue of the Annals of ...
Surgery
May 08, 2013 |
not rated yet |
0
Ambrisentan not effective in idiopathic pulmonary fibrosis
(HealthDay)—The endothelin A receptor-selective antagonist ambrisentan is not effective for reducing the rate of idiopathic pulmonary fibrosis (IPF) progression, according to a study published in the May ...
Diseases, Conditions, Syndromes
May 07, 2013 |
not rated yet |
0
Genetic variant may explain weight loss post-RYGB surgery
(HealthDay)—A genetic variant associated with weight loss after Roux-en-Y gastric bypass (RYGB) surgery has been identified, according to a study published in the May 2 issue of the American Journal of ...
Genetics
May 07, 2013 |
not rated yet |
0
In-hospital mortality no different at critical access hospitals
(HealthDay)—For eight inpatient surgical procedures, mortality is similar at critical access hospitals (CAHs) and non-CAHs, but costs are higher at CAHs, according to a study published online May 1 in JAMA Su ...
Surgery
May 05, 2013 |
not rated yet |
0
Comprehensive analysis supports SERMs for cutting breast cancer
(HealthDay)—Treatment with selective estrogen receptor modulators (SERMs) is associated with a significant reduction in the incidence of breast cancer, especially for the first five years after treatment, ...
Cancer
Apr 30, 2013 |
not rated yet |
0
High doses of saw palmetto appear safe over 18 months
(HealthDay)—Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.
Diseases, Conditions, Syndromes
Apr 29, 2013 |
5 / 5 (1) |
0
Surgeon variation affects QoL after prostatectomy
(HealthDay)—There is a significant association between performing surgeons and patient quality of life following radical prostatectomy, according to a study published in the April issue of The Journal of ...
Cancer
May 15, 2013 |
not rated yet |
0
SPACE, RF ablation combo safe and effective for lung cancer
(HealthDay)—For unresectable lung tumors, the combination of segmental pulmonary arterial chemoembolization (SPACE) and percutaneous radiofrequency (RF) ablation helps achieve better local tumor progression ...
Cancer
May 15, 2013 |
not rated yet |
0
